含有1个向性跨膜BAX抑制剂的基因减轻了病态心脏缩
Ke-Qiong Deng1,2,3,4, Guang-Nian Zhao2,3,5,4, Zhihua Wang1,2,3,4
1Department of Cardiology, Renmin Hospital of Wuhan University, China (K.-Q.D., Z.W., P.Z., Z.-G.S., H.L.).
Circulation
|December 13, 2017
概括
通过增强托尔类受体4 (TLR4) 的溶酶体降解来防止心脏缩. 针对TMBIM1为心力衰竭提供了潜在的治疗策略.
科学领域:
- 心血管生物学
- 分子医学
- 细胞信号传输
背景情况:
- 心脏缩和心力衰竭是全球死亡的主要原因.
- 细胞组件的 lysosomal 降解受损导致心脏缩的进展.
- 这些过程背后的精确分子机制仍然不完全理解.
研究的目的:
- 研究含有1 (TMBIM1) 的跨膜BAX抑制因子在心脏缩中的作用.
- 阐明TMBIM1影响心脏缩的分子机制.
- 评估TMBIM1在病态心脏缩中的治疗潜力.
主要方法:
- 在人类心力衰竭和小鼠心脏缩模型中评估TMBIM1表达.
- 产生和分析心脏特异性TMBIM1淘汰和过度表达的小鼠模型.
- 采用转录组分析,共聚焦成像,共免疫沉和动物模型 (包括非人类灵长类动物) 来研究TMBIM1的功能和治疗效果.
主要成果:
- 在过度缩的心脏中,TMBIM1表达被降低;其沉默加剧了过度缩,而过度表达则改善了它.
- TMBIM1通过托尔类受体4 (TLR4) 信号通路调节心脏缩.
- TMBIM1与TSG101直接相互作用,促进多细胞体的形成,促进激活的TLR4的溶解体降解.
结论:
- TMBIM1通过促进激活的TLR4的溶酶体降解来预防病态心脏缩.
- 在心脏缩中,TMBIM1是多胞体形成的关键调节剂.
- 针对TMBIM1代表了对心脏缩和心力衰竭的有前途的新疗法.
相关概念视频
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
539
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
539
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.2K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.2K
01:29Cardiomyopathy V: Interprofessional Care
483
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
483
01:29Heart Failure II: Pathophysiology
1.0K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K